Connection

Fabian Sanchis-Gomar to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Fabian Sanchis-Gomar has written about Coronavirus Infections.
Fabian Sanchis-Gomar
Connection Strength
0.438
Coronavirus Infections
  1. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
    View in: PubMed
    Score: 0.028
  2. Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? Am J Cardiovasc Drugs. 2020 Oct; 20(5):413-418.
    View in: PubMed
    Score: 0.028
  3. In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
    View in: PubMed
    Score: 0.028
  4. Why is COVID-19 especially impacting the African American population? Ann Med. 2020 11; 52(7):331-333.
    View in: PubMed
    Score: 0.028
  5. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? Eur Heart J. 2020 07 01; 41(32):3092-3093.
    View in: PubMed
    Score: 0.028
  6. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
    View in: PubMed
    Score: 0.028
  7. Statins and other drugs: Facing COVID-19 as a vascular disease. Pharmacol Res. 2020 09; 159:105033.
    View in: PubMed
    Score: 0.028
  8. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 05 26; 7(2):85-90.
    View in: PubMed
    Score: 0.028
  9. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
    View in: PubMed
    Score: 0.028
  10. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
    View in: PubMed
    Score: 0.028
  11. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
    View in: PubMed
    Score: 0.027
  12. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur J Prev Cardiol. 2020 06; 27(9):906-908.
    View in: PubMed
    Score: 0.027
  13. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
    View in: PubMed
    Score: 0.027
  14. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May - Jun; 63(3):390-391.
    View in: PubMed
    Score: 0.027
  15. Cardiac Injury in COVID-19-Echoing Prognostication. J Am Coll Cardiol. 2020 11 03; 76(18):2056-2059.
    View in: PubMed
    Score: 0.007
  16. SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020014.
    View in: PubMed
    Score: 0.007
  17. Updates on laboratory investigations in coronavirus disease 2019 (COVID-19). Acta Biomed. 2020 09 07; 91(3):e2020030.
    View in: PubMed
    Score: 0.007
  18. Repeated Testing in SARS-CoV-2 Infection. Mayo Clin Proc. 2020 10; 95(10):2283-2284.
    View in: PubMed
    Score: 0.007
  19. Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. Nutrients. 2020 May 26; 12(6).
    View in: PubMed
    Score: 0.007
  20. COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
    View in: PubMed
    Score: 0.007
  21. Active smoking and COVID-19: a double-edged sword. Eur J Intern Med. 2020 07; 77:123-124.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.